🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share comparison images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Some professionals said the demand for retatrutide could be connected to the rising price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Removal

Based on the social media company, the service has taken down problematic content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Online Trading Activities

Research also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, filled with images of slimming results, positive testimonials and step-by-step instructions for preparing or administering at home.

After minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Details and Costs

Inside these groups, messages show black plastic packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to potentially serious medical dangers”.